Home
Browse
Search
Statistics
About
Usage
PMID: 20423679
Bodas M, Vij N
The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential.
Discov Med. 2010 Apr;9(47):346-56.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
57
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 20423679:57:50
status:
NEW
view ABCC7 p.Gly551Asp details
Weber et al. (2001) evaluated cells with the CFTR
G551D
mutation that produces a protein that is trafficked normally to the cell membrane but lacks Cl-channel function.
Login to comment
58
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 20423679:58:5
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 20423679:58:187
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 20423679:58:189
status:
NEW
view ABCC7 p.Gly551Asp details
Both
G551D
and ΔF508- mutations were associated with the upregulation of NFκB activation and increased production of IL-8 although the NFκB activation in the presence of
G551D m
utation is only about 2-fold as compared to 7-fold for ΔF508.
Login to comment
102
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 20423679:102:200
status:
NEW
view ABCC7 p.Gly542* details
Recent data suggest that the higher inflammation in ΔF508 CF could be a consequence of fewer CFTR molecules at the membrane, as would be predicted also with other rare CF stop mutations such as
G542X
(McCormick et al., 2002).
Login to comment